Displaying 49 - 60 of 160
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Immune-Mediated and Cholestatic Diseases
4

AdvanzPharma: Shifting Paradigms in PBC Management - EASL Congress 2024

View
Displaying 49 - 60 of 160